Jemperli (Dostarlimab-gxly): An unprecedented cancer trial
Ann Med Surg (Lond)
.
2022 Jun 25:79:104047.
doi: 10.1016/j.amsu.2022.104047.
eCollection 2022 Jul.
Authors
Eman Ali
1
,
Aayat Ellahi
2
,
Mariam Adil
1
,
Asim Shaikh
1
,
Zunera Huda
1
Affiliations
1
Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
2
Department of Internal Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
PMID:
35860105
PMCID:
PMC9289402
DOI:
10.1016/j.amsu.2022.104047
No abstract available
Keywords:
Bowel cancer; Cancer trial; Colorectal cancer; Experimental drug.